Grants.gov · forecast:forecasted
Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)
- Verified from source 14 days ago
- Updated 24 days ago
- Amendment detected
- Agency
- Centers for Disease Control - NCHHSTP
- Office
- HHS-CDC-NCHHSTP
- Type
- forecast:forecasted
- Kind
- grant
- Posted
- Jun 9, 2026
- Place
- —
- Notice ID
- 362731
- Source
- Grants.gov
- First seen
- Sep 6, 2026, 5:39 AM UTC
Full scope
This NOFO supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States. Key strategies include viral hepatitis outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and acute, chronic, and perinatal hepatitis C. Surveillance activities include developing and utilizing disease registries, conducting data matching, generating data summaries, utilizing data to monitor program progress and inform program activities and to enhance case investigations for data-to-care opportunities, and strengthen…
Description
This NOFO supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States. Key strategies include viral hepatitis outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and acute, chronic, and perinatal hepatitis C. Surveillance activities include developing and utilizing disease registries, conducting data matching, generating data summaries, utilizing data to monitor program progress and inform program activities and to enhance case investigations for data-to-care opportunities, and strengthening health department infrastructure to expand surveillance capacity. Prevention activities include supporting viral hepatitis elimination planning, partnerships, and coordination in high-impact and healthcare settings, increasing hepatitis B and hepatitis C testing, treatment, and service integration in high-impact settings, and developing perinatal hepatitis C programs. Expected outcomes include improved surveillance and reporting of viral hepatitis, improved strategic planning and partner collaboration in viral hepatitis elimination, and expanded access to viral hepatitis prevention, diagnosis, and treatment in high-impact settings.
This multi-component NOFO includes two required components and two optional components:
Component 1: Outbreak Response and Surveillance (Required)
Component 2: Planning, Partnerships, and Promotion (Required)
Component 3: Testing, Treatment, and Prevention (Optional)
Component 4: Perinatal Hepatitis C Program (Optional)
This NOFO is alignment with CDC priorities.
Eligibility
Eligible applicants include: The 51 state health departments or their bona fide agents, including the District of Columbia. Local health agencies or their bona fide agents. If the city does not have a public health department, then the county covering the jurisdiction may apply (i.e., Los Angeles, CA covered by Los Angeles County and Phoenix, AZ covered by Maricopa County). All U.S. territories Bona fide agents must submit documentation that demonstrates their arrangement with the eligible applicant.
Contacts
-
Clarisse Tsang
Related links
Full record synced 7 days ago from Grants.gov (forecast)